|
1
|
Hay N and Sonenberg N: Upstream and
downstream of mTOR. Genes Dev. 18:1926–1945. 2004. View Article : Google Scholar
|
|
2
|
Gridelli C, Maione P and Rossi A: The
potential role of mTOR inhibitors in non-small cell lung cancer.
Oncologist. 13:139–147. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mita MM and Tolcher AW: The role of mTOR
inhibitors for treatment of sarcomas. Curr Oncol Rep. 9:316–322.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim KW, Mutter RW, Cao C, et al: Autophagy
for cancer therapy through inhibition of pro-apoptotic proteins and
mammalian target of rapamycin signaling. J Biol Chem.
281:36883–36890. 2006. View Article : Google Scholar
|
|
5
|
Hung JY, Hsu YL, Li CT, et al: 6-Shogaol,
an active constituent of dietary ginger, induces autophagy by
inhibiting the AKT/mTOR pathway in human non-small cell lung cancer
A549 cells. J Agric Food Chem. 57:9809–9816. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tan ML, Ooi JP, Ismail N, Moad AI and
Muhammad TS: Programmed cell death pathways and current antitumor
targets. Pharm Res. 26:1547–1560. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Amaravadi RK and Thompson CB: The roles of
therapy-induced autophagy and necrosis in cancer treatment. Clin
Cancer Res. 13:7271–7279. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pattingre S, Espert L, Biard-Piechaczyk M
and Codogno P: Regulation of macroautophagy by mTOR and Beclin 1
complexes. Biochimie. 90:313–323. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu D, Yang Y, Liu Q and Wang J:
Inhibition of autophagy by 3-MA potentiates cisplatin-induced
apoptosis in esophageal squamous cell carcinoma cells. Med Oncol.
28:105–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kanematsu S, Uehara N, Miki H, et al:
Autophagy inhibition enhances sulforaphane-induced apoptosis in
human breast cancer cells. Anticancer Res. 30:3381–3390.
2010.PubMed/NCBI
|
|
11
|
Ren Y, Huang F, Liu Y, Yang Y, Jiang Q and
Xu C: Autophagy inhibition through PI3K/Akt increases apoptosis by
sodium selenite in NB4 cells. BMB Rep. 42:599–604. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ito Y, Sasaki Y, Horimoto M, et al:
Activation of mitogen-activated protein kinases/extracellular
signal-regulated kinases in human hepatocellular carcinoma.
Hepatology. 27:951–958. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sasaki K, Hitora T, Nakamura O, Kono R and
Yamamoto T: The role of MAPK pathway in bone and soft tissue
tumors. Anticancer Res. 31:549–553. 2011.PubMed/NCBI
|
|
14
|
Carracedo A, Ma L, Teruya-Feldstein J, et
al: Inhibition of mTORC1 leads to MAPK pathway activation through a
PI3K-dependent feedback loop in human cancer. J Clin Invest.
118:3065–3074. 2008.PubMed/NCBI
|
|
15
|
Huang S, Yang ZJ, Yu C and Sinicrope FA:
Inhibition of mTOR kinase by AZD8055 can antagonize
chemotherapy-induced cell death through autophagy induction and
down-regulation of p62/sequestosome 1. J Biol Chem.
286:40002–40012. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamamoto M, Suzuki SO and Himeno M:
Resveratrol-induced autophagy in human U373 glioma cells. Oncol
Lett. 1:489–493. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ozzello L, Stout AP and Murray MR:
Cultural characteristics of malignant histiocytomas and fibrous
xanthomas. Cancer. 16:331–344. 1963. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
O’Brien JE and Stout AP: Malignant fibrous
xanthomas. Cancer. 17:1445–1455. 1964.
|
|
19
|
Wardelmann E, Chemnitz JM and Wendtner CM:
Targeted therapy of soft tissue sarcomas. Onkologie. 35(Suppl 1):
21–27. 2012. View Article : Google Scholar
|
|
20
|
Arslan MA, Kutuk O and Basaga H: Protein
kinases as drug targets in cancer. Curr Cancer Drug Targets.
6:623–634. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kiyozuka Y, Nakagawa H, Uemura Y, et al:
Novel cell lines established from a human myxoid malignant fibrous
histiocytoma arising in the uterus. Cancer Genet Cytogenet.
127:7–15. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yousefi S, Perozzo R, Schmid I, et al:
Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis.
Nat Cell Biol. 8:1124–1132. 2006. View
Article : Google Scholar
|
|
23
|
Perez-Carrion MD, Perez-Martinez FC,
Merino S, et al: Dendrimer-mediated siRNA delivery knocks down
Beclin 1 and potentiates NMDA-mediated toxicity in rat cortical
neurons. J Neurochem. 120:259–268. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pankiv S, Clausen TH, Lamark T, et al:
p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of
ubiquitinated protein aggregates by autophagy. J Biol Chem.
282:24131–24145. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Joselin AP, Schulze-Osthoff K and Schwerk
C: Loss of Acinus inhibits oligonucleosomal DNA fragmentation but
not chromatin condensation during apoptosis. J Biol Chem.
281:12475–12484. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Okuno S: Mammalian target of rapamycin
inhibitors in sarcomas. Curr Opin Oncol. 18:360–362. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakamura O, Hitora T, Akisue T, Kawamoto
T, Yamagami Y and Yamamoto T: Inhibition of induced autophagy
increases apoptosis of Nara-H cells. Int J Oncol. 39:1545–1552.
2011.
|
|
28
|
Li B, Takeda T, Tsuiji K, et al: Curcumin
induces cross-regulation between autophagy and apoptosis in uterine
leiomyosarcoma cells. Int J Gynecol Cancer. 23:803–808. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guertin DA and Sabatini DM: The
pharmacology of mTOR inhibition. Sci Signal. 2:pe242009.PubMed/NCBI
|
|
30
|
Yang Q and Guan KL: Expanding mTOR
signaling. Cell Res. 17:666–681. 2007. View Article : Google Scholar
|
|
31
|
Kim MS, Kuehn HS, Metcalfe DD and
Gilfillan AM: Activation and function of the mTORC1 pathway in mast
cells. J Immunol. 180:4586–4595. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kuo PL, Hsu YL and Cho CY: Plumbagin
induces G2-M arrest and autophagy by inhibiting the AKT/mammalian
target of rapamycin pathway in breast cancer cells. Mol Cancer
Ther. 5:3209–3221. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Han W, Sun J, Feng L, et al: Autophagy
inhibition enhances daunorubicin-induced apoptosis in K562 cells.
PLoS One. 6:e284912011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Saini KS, Loi S, de Azambuja E, et al:
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the
treatment of breast cancer. Cancer Treat Rev. 39:935–946. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang J, Whiteman MW, Lian H, et al: A
non-canonical MEK/ERK signaling pathway regulates autophagy via
regulating Beclin 1. J Biol Chem. 284:21412–21424. 2009. View Article : Google Scholar : PubMed/NCBI
|
